Guidelines for Point-of-Care Fluorescence Imaging for Detection of Wound Bacterial Burden Based on Delphi Consensus
Alisha R. Oropallo1, Charles Andersen2, Raymond Abdo3, Jenny Hurlow4, Martha Kelso5, Mark Melin6 and Thomas E. Serena7
1Comprehensive Wound Healing Center and Hyperbarics, Department of Vascular Surgery, Zucker School of Medicine Hofstra/Northwell, Hempstead, NY 11549, USA
2Wound Care Clinic, Madigan Army Medical Center Joint Base Lewis-McChord, Renton, WA 98431, USA
3St. Louis Foot & Ankle, LLC., St. Louis, MO 63109, USA
4Consultant Wound Care Specialized Nurse Practitioner, Memphis, TN 37501, USA
5Wound Care Plus, LLC., Blue Springs, MO 64015, USA
6M Health Fairview Wound Healing Institute, South Campus, Edina, MN 55435, USA
7SerenaGroup Research Foundation, 125 Cambridge Park Dr., Cambridge, MA 02140, USA
Diagnostics 2021, 11(7), 1219
Related Publications
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
MolecuLight Headquarters
425 University Avenue Suite 700 Toronto, ON M5G 1T6 Canada
US Address MolecuLight Corp. 2403 Sidney Street, Suite 286 Pittsburgh, PA 15203
T. 1-877-818-4360
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com
©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.